Anti-FGFR1/ BFGFR/ CD331 monoclonal antibody
Anti-FGFR1/ BFGFR/ CD331 antibody for FACS & in-vivo assay
Go to FGFR1/FGFR1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T47101-Ab-1/ GM-Tg-hg-T47101-Ab-2 | Anti-Human FGFR1 monoclonal antibody | Human |
GM-Tg-rg-T47101-Ab-1/ GM-Tg-rg-T47101-Ab-2 | Anti-Rat FGFR1 monoclonal antibody | Rat |
GM-Tg-mg-T47101-Ab-1/ GM-Tg-mg-T47101-Ab-2 | Anti-Mouse FGFR1 monoclonal antibody | Mouse |
GM-Tg-cynog-T47101-Ab-1/ GM-Tg-cynog-T47101-Ab-2 | Anti-Cynomolgus/ Rhesus macaque FGFR1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T47101-Ab-1/ GM-Tg-felg-T47101-Ab-2 | Anti-Feline FGFR1 monoclonal antibody | Feline |
GM-Tg-cang-T47101-Ab-1/ GM-Tg-cang-T47101-Ab-2 | Anti-Canine FGFR1 monoclonal antibody | Canine |
GM-Tg-bovg-T47101-Ab-1/ GM-Tg-bovg-T47101-Ab-2 | Anti-Bovine FGFR1 monoclonal antibody | Bovine |
GM-Tg-equg-T47101-Ab-1/ GM-Tg-equg-T47101-Ab-2 | Anti-Equine FGFR1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T47101-Ab-1/ GM-Tg-hg-T47101-Ab-2; GM-Tg-rg-T47101-Ab-1/ GM-Tg-rg-T47101-Ab-2; GM-Tg-mg-T47101-Ab-1/ GM-Tg-mg-T47101-Ab-2; GM-Tg-cynog-T47101-Ab-1/ GM-Tg-cynog-T47101-Ab-2; GM-Tg-felg-T47101-Ab-1/ GM-Tg-felg-T47101-Ab-2; GM-Tg-cang-T47101-Ab-1/ GM-Tg-cang-T47101-Ab-2; GM-Tg-bovg-T47101-Ab-1/ GM-Tg-bovg-T47101-Ab-2; GM-Tg-equg-T47101-Ab-1/ GM-Tg-equg-T47101-Ab-2 |
Products Name | Anti-FGFR1 monoclonal antibody |
Format | mab |
Target Name | FGFR1 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-FGFR1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Biosimilar | GMP-Bios-INN-826 | Pre-Made Efruxifermin Biosimilar, Fusion Protein targeting FGFR1 fused with human IGHG1 Fc (Fragment constant) via a peptidyl linker: Recombinant therapeutic protein targeting BFGFR/CD331/CEK/ECCL/FGFBR/FGFR-1/FLG/FLT-2/FLT2/HBGFR/HH2/HRTFDS/KAL2/N-SAM/OGD/bFGF-R-1 |
Target Antigen | Products Developing | Multi-species FGFR1/ BFGFR/ CD331 VLP (virus-like particle) (Products Developing) |
Cytokine | GM-Tg-g-T47101-Ag-1 | Fibroblast growth factor receptor 1 (FGFR1) protein |
ORF Viral Vector | pGMLP003322 | human FGFR1 Lentivirus plasmid |
ORF Viral Vector | vGMLP003322 | human FGFR1 Lentivirus particle |
ORF Viral Vector | pGMLPm001261 | mouse Fgfr1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm001261 | mouse Fgfr1 Lentivirus particle |
Target information
Target ID | GM-T47101 |
Target Name | FGFR1 |
Gene ID | 2260,14182,79114,700126,100856477,101086055,281768,100057614 |
Gene Symbol and Synonyms | bFGF-R,bFGF-R-1,BFGFR,c-fgr,CD331,CEK,Eask,ECCL,FGFBR,FGFR-1,FGFR-I,FGFR1,FGFRI,FLG,FLG-1,FLT-2,FLT2,Fr1,HBGFR,HH2,HRTFDS,Hspy,KAL2,MFR,N-SAM,OGD |
Uniprot Accession | P11362,Q04589 |
Uniprot Entry Name | FGFR1_HUMAN,FGFR1_RAT |
Protein Sub-location | Transmembrane Protein |
Category | Therapeutics Target, INN Index, Cytokine Target |
Disease | Juvenile astrocytoma |
Gene Ensembl | ENSG00000077782 |
Target Classification | Kinase |
The target: FGFR1, gene name: FGFR1, also named as BFGFR, CD331, CEK, ECCL, FGFBR, FGFR-1, FLG, FLT-2, FLT2, HBGFR, HH2, HRTFDS, KAL2, N-SAM, OGD, bFGF-R-1. The protein encoded by this gene is a member of the fibroblast growth factor receptor (FGFR) family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member binds both acidic and basic fibroblast growth factors and is involved in limb induction. Mutations in this gene have been associated with Pfeiffer syndrome, Jackson-Weiss syndrome, Antley-Bixler syndrome, osteoglophonic dysplasia, and autosomal dominant Kallmann syndrome 2. Chromosomal aberrations involving this gene are associated with stem cell myeloproliferative disorder and stem cell leukemia lymphoma syndrome. Alternatively spliced variants which encode different protein isoforms have been described; however, not all variants have been fully characterized. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.